Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Devnyst O Nystatin Tablets IP 500,000 IU
Devnyst O, provided by Lexaro Healthcare, contains 500,000 IU of Nystatin in each tablet. This formulation is designed to deliver potent antifungal activity to combat fungal infections, particularly those affecting the gastrointestinal tract.
Uses of Devnyst O Nystatin Tablets IP 500,000 IU
Devnyst O is primarily prescribed for:
Treating fungal infections of the gastrointestinal tract, including Candida infections.
Managing oral thrush and esophageal candidiasis.
Providing effective treatment for fungal infections that do not respond to topical antifungal treatments.
Preventing fungal infections in immunocompromised patients or those undergoing certain medical treatments.
Benefits of Devnyst O Nystatin Tablets IP 500,000 IU
Provides effective antifungal activity against Candida species and other fungi.
Targets fungal infections in the gastrointestinal tract, including oral and esophageal infections.
Helps to alleviate symptoms associated with fungal infections, such as discomfort and irritation.
Convenient tablet formulation for oral administration.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Devnyst O Nystatin Tablets IP 500,000 IU
Nystatin is an antifungal agent that works by binding to sterols in the fungal cell membrane, specifically ergosterol. This binding disrupts the integrity of the cell membrane, leading to increased membrane permeability and leakage of essential intracellular components. As a result, Nystatin effectively inhibits fungal growth and leads to the death of the fungal cells. Devnyst O provides targeted antifungal action in the gastrointestinal tract, helping to control and eliminate fungal infections.